Panlin Capital
Shanghai, Shanghaipanlincap.com
Overview
Panlin Capital is a Shanghai-based asset management firm that focuses on early stage investments in technology, healthcare, consumer goods, life science and retail related sectors across China . Panlin Capital targets start-ups specialized in biotechnology and data intelligence, following the investment theme of 'industrial upgrading driven by technology innovation' .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Shanghai UniXell Biotechnology | Apr 2025 | Series A | Co-investor |
| Shanghai Chipanalog Microelectronics Co., Ltd. | Aug 2023 | Series C Extension | Co-investor |
| Shanghai Chipanalog Microelectronics Co., Ltd. | Jan 2023 | Series C Extension | Co-investor |
| NuProbe | Jun 2022 | Series C | Lead |
| PPIO Cloud Computing Shanghai Co., Ltd. | May 2022 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.